Download Library

 
 
 
Download Library
Document Type
DVd vs Vd in RRMM: Efficacy and safety update (CASTOR) - ASCO abstract - May 2017 (Lentzsch)
PDF
87.3 KB
Q1 2017 Results Podcast
MP3
22.2 MB
Genmab Q1 2017 Results Presentation
PDF
250.9 KB
Interim Report for the First Quarter 2017
pdf
535.0 KB
Election Results of the Annual General Meeting 2017
PDF
91.4 KB
Scientific Committee Charter
PDF
155.3 KB
AGM 2017 Presentation
PDF
1.4 MB
Genmab 2016 Annual Report
pdf
8.7 MB
Full Year 2016 Results Podcast
MP3
28.2 MB
Full Year 2016 Results Presentation
PDF
488.8 KB
CSR Report 2016
PDF
274.2 KB
Corporate Governance Report 2016 - English
PDF
332.4 KB
Investor Fact Sheet
PDF
253.1 KB
35th Annual J.P. Morgan Healthcare Conference, San Francisco, CA, US - January 2017
PDF
1.2 MB
Use of Montelukast to Reduce Infusion Reactions in an Early Access Program (EAP) of Daratumumab in United States Patients With Relapsed or Refractory Multiple Myeloma - ASH Poster - December 2016 (Chari)
PDF
545.4 KB
Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone Alone for Relapsed or Refractory Multiple Myeloma Based on Prior Treatment Exposure: Updated Efficacy Analysis of CASTOR - ASH Poster - December 2016 (Chanan-Khan)
PDF
470.6 KB
Cost-effective Analysis of Ofatumumab for Relapsed CLL - ASH poster - December 2016 (Tremblay)
PDF
279.5 KB
Genmab's ASH 2016 Data Review Meeting, San Diego, CA - December 2016
PDF
3.3 MB
High-Parameter Mass Cytometry Evaluation of Relapsed/Refractory MM Pts Treated with Daratumumab Supports Immune Modulation As a Novel Mechanism of Action - ASH poster - December 2016 (Adams)
PDF
4.9 MB
DRd Induces Clonality Increase and T-Cell Expansion: Results from a Phase 3 Randomized Study (POLLUX) - ASH poster - December 2016 (Chiu)
PDF
888.9 KB
Efficacy of DVd Versus Vd in Relapsed or Refractory Myeloma Based on Prior Lines of Therapy: Updated Analysis of Castor - ASH presentation - December 2016 (Mateos)
PDF
1.3 MB
Efficacy of DRd Versus Rd in Relapsed or Refractory MM Patients with 1 to 3 Prior Lines of Therapy: Updated Analysis of Pollux - ASH presentation - December 2016 (Usmani)
PDF
1.4 MB
Phase 1b Study to Assess Subcutaneous Daratumumab in pts with Relapsed or Refractory MM (PAVO) - ASH presentation - December 2016 (Usmani)
PDF
981.3 KB

Page: First Previous
1
2
3
4
5
6
7
8
...
19
Next Last

 
 
 

Please be advised that additional documents and media, such as fact sheets and conference call webcasts, are available only in English and can be accessed by clicking on the English tab.

 

Download Library
Document Type
Kvartalsrapport 1.kvartal 2002
PDF
66.2 KB
Kvartalsrapport 3. kvartal 2001
PDF
161.0 KB
Halvårsrapport Første halvår 2001
PDF
147.7 KB
Kvartalsrapport 1.kvartal 2001
PDF
145.0 KB
Årsregnskab 2001
PDF
429.6 KB
Kvartalsrapport - 3. kvartal 2000
PDF
59.2 KB
Årsregnskab 2000
PDF
592.8 KB
Page: First Previous
1
2
3
4